Bitget App
Trade smarter
Buy cryptoMarketsTradeFuturesEarnAISquareMore
BRIEF-Kymera Therapeutics Q2 EPS USD -0.62

BRIEF-Kymera Therapeutics Q2 EPS USD -0.62

ReutersReuters2026/08/05 11:01

Aug 05 (Reuters) - Kymera Therapeutics Q2 revenue USD 65 million vs. IBES estimate USD 31.2 million.

  • Q2 net income USD -61.211 million
  • Q2 operating expenses USD 140.607 million
0
0

Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.

Understand the market, then trade.
Bitget offers one-stop trading for cryptocurrencies, stocks, and gold.
Trade now!